Gain Therapeutics Announces Announces Conference Participation During J.P. Morgan Healthcare Conference Week Life Science Investing
Praxis Precision Medicines, Inc. Announces Pricing of $575 Million Public Offering Life Science Investing
Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock Life Science Investing
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026 Life Science Investing
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference Life Science Investing
